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Abstract  
BACKGROUND: There is a general agreement that, besides survival, the quality of life is a highly relevant 
outcome in the evaluation of treatment in patients with the end-stage renal disease. Moreover, it is very important 
to determine whether the quality of life impacts survival. 
AIM: This study aims to assess whether changes or absolute scores of the quality of life (QOL) measurements 
better predict mortality in dialysis patients. 
MATERIAL AND METHODS: In a longitudinal study comprising 162 prevalent hemodialysis patients QOL was 
assessed with the 36-item - Short Form Health Survey Questionnaire (SF-36) at baseline and after 12 months. 
Patients were followed for 60 months. Mortality risk was assessed using Cox proportional hazards analysis for 
patients with below and above median levels of both physical and mental QOL component scores (PCS and 
MCS, respectively). 
RESULTS: At the beginning of the study the mean Physical Component score was 47.43 ± 26.94 and mean 
Mental Component Score was slightly higher 50.57 ± 24.39. Comparative analysis of the changes during the first 
year showed a marked deterioration of all quality of life scores in surviving patients. The 5-point decline for PCS 
was noted in 39 (24%) patients and 42 (26%) for MCS. In the follow-up period of 60 months, 69 (43%) patients 
died. In the Cox analysis, mortality was significantly associated with lower PCS: HR = 2.554 [95% confidence 
interval (CI): 1.533-4.258], (P < 0.000) and lower MCS: 2.452 (95%CI: 1.478-4.065), P < 0.001. The patients who 
had lower levels of PCS and MCS in the second QOL survey 1 year later, had similarly high mortality risk: 3.570 
(95%CI: 1.896-6.727, P < 0.000); 2.972 (95%CI: 1.622-5.490, P < 0.000), respectively. The hazard ratios for 
mortality across categories for the change of PCS and MCS were not significant. In the multivariate model 
categorising the first and second scores as predictors and adjusted for age, only the second PCS and MCS score 
were associated with mortality. 
CONCLUSION: Low QOL scores are associated with mortality in repeated measurements, but only the more 
recent overwhelmed the power of the decline. 
 
 
 
 
 
 
 
 
Introduction 
 
Several studies have investigated the 
associations of longitudinal changes of quality of life 
(QOL) with mortality in hemodialysis patients. There is 
still controversy if the absolute values or relative 
changes are stronger predictors of mortality [1][2][3].  
This study aims to assess whether changes 
or absolute scores of life quality measurements better 
predict mortality.  
 
Material and Methods 
 
We conducted a longitudinal study comprising 
162 prevalent hemodialysis patients in one dialysis 
centre. Patients with age above 18 years and regular 
HD treatment for at least 3 months were included in 
the study. The lack of mental or physical capacity to 
communicate were exclusion criteria. The 
hemodialysis (HD) prescription in our study included 4 
to 5 hours of HD thrice weekly for all patients with flow 
rates of 280 to 300 mL/min using a standard 
bicarbonate dialysis solution and low flux synthetic 
membranes with a surface area of 1.3 to 1.8 m
2
. Data 
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was collected using medical histories and interviews 
for demographic and clinical indices.  
QOL was assessed with the 36-item-Short 
Form Health Survey Questionnaire (SF-36) [4]. The 
SF-36 is a generic multidimensional instrument 
consisting of eight multi-item scales representing 
physical functioning, social functioning, role limitations 
caused by physical problems, and role limitations 
caused by emotional problems, mental health, vitality, 
bodily pain, and general health perceptions. The scale 
scores were transformed to a 0 to 100 scale, with a 
higher score indicating a better QOL. Finally, the 
physical and mental components of the eight scales 
were combined into a physical (PCS) and mental 
(MCS) component summary score. The PCS primarily 
reflects the dimensions of physical functioning, role 
limitations caused by physical health problems, pain, 
and general health perception. The MCS reflects 
primarily mental health, role limitations caused by 
emotional problems, social functioning, and vitality.  
At the beginning of the study, during a 
regularly scheduled mid-week HD treatment, after 
being given a brief explanation, for each patient, QOL 
assessment using a 36-Item Short Form Health 
Survey Questionnaire (SF-36) was performed by a 
full-time employed psychologist. Assistance was 
available for patients who were illiterate, with an 
interactive approach. The SF-36 questionnaire was 
translated and adapted for the Macedonian 
population. Informed consent was provided. 
Patients were followed for 60 months, until a 
change of dialysis modality, transplantation or death. 
Those transferred to other dialysis centres were 
continued to be followed. At 12 months of the study, 
the second SF-36 measurement was performed.  
Statistical analysis was performed with SPSS 
16.0 for Windows. Descriptive data were presented as 
mean±standard deviation (SD), or a the median. 
Percentages are given for categorical variables. 
Mortality risk was assessed using Cox proportional 
hazards analysis for patients with below and above 
median levels of both QOL component scores. A P-
value of 0.05 or less was considered significant. 
 
 
Results 
 
The mean age of study participants was 56 
years and mean dialysis vintage was 100 months. 
53% of patients were male, and 24% were diabetics. 
Most of the patients were dialysed for 4 hours, and 
had good anaemia management, as shown in Table 
1. 
At the beginning of the study, the mean 
component physical score was 47.43 ± 26.94 and 
mean mental component score was slightly higher at 
50.57 ± 24.39.  
Table 1: Patients characteristics (N = 162) 
N = 162 Mean ± SD/% 
Age (years) 56,15 ± 13.35 
Male (%) 85 (53%) 
Dialysis vintage (months) 100.69 ± 76.08 
Diabetes (%) 40 (24%) 
Hemoglobin (g/L) 116.5 ± 8.5 
Albumin (g/L) 38.8 ± 2.5 
C-reactive protein (mg/L) 6.95 ± 8.46 
Dialysis session time (hours) 4.07 ± 0.21 
spKt/v     1.38 ± 0.20 
Body mass index (kg/m²) 23.86 ± 4.6 
 
Comparative analysis of the changes during 
the first year showed a marked deterioration of all 
quality of life scores in surviving patients (Table 2). 
The median level of PCS scores at twelve months 
was 43, and for MCS the value was 51. The 5-point 
decline for PCS was noted in 39 (24%) patients and 
42 (26%) for MCS. Improvement of both scores was 
noted in 8 (6%) patients. The mean delta values 
varied in different QOL domains from minus 0.2 to 
minus 7.9 (Physical functioning: -4.2, Role-physical: -
4.2, bodily pain: -7.2, general health: - 2.0, Role-
emotional: -3.0, Social functioning: -4.9, Vitality: -7.9, 
Mental health: -0.2). Overall delta for PCS was -3.8 
and for MCS was -3.7 points. The median of changes 
for both scores was 0. 
Table 2: Comparison of Quality of life scores in two annual 
measurements 
SF-36 scores 
Patients at the start    of 
the study (N = 140) 
Survived after 12 
months (N = 140) 
P 
Physical functioning 53.87 ± 32.58 49.60 ± 32.89 0.003 
Role-physical 42.26 ± 42.25 39.86 ± 41.10 0.204 
Bodily Pain 63.45 ± 56.17 56.17 ± 30.69 0.0001 
General health 36.48 ± 18.00 34.47 ± 19.23 0.052 
Role-emotional 48.57 ± 24.98 45.57 ± 24.19 0.010 
Social functioning 61.96 ± 31.83 57.12 ± 33.27 0.0001 
Vitality 55.64 ± 20.16 49.65 ± 44.93 0.002 
Mental health 52.15 ± 23.50 55.40 ± 19.47 0.833 
Physical component 
(PCS) score 
48.93 ± 26.10 45.13 ± 26.38 0.0001 
Mental component 
(MCS) score 
52.50 ± 23.50 48.44 ± 24.61 0.0001 
 
In the follow-up period of 60 months, 69 
(43%) patients died. We evaluated associations 
between mortality and the absolute PCS scores, and 
also the different grades of scores declinations. In the 
univariate analysis the basal PCS values (45 < PCS > 
45), PCS values at twelve months (43 < PCS > 43), 
delta PCS (declination more than 5 points) < ∆PCS > 
(declination more than 5 points), delta PCS 
(declination more than 10 points) < ∆PCS > 
(declination more than 10 points), were included. In 
the Cox analysis, mortality was significantly 
associated with lower PCS: HR = 2.554 [95% 
confidence interval (CI): 1.533-4.258], (P < 0.000) and 
lower MCS: 2.452 (95%CI: 1.478-4.065), P < 0.001. 
The patients who had lower levels of PCS and MCS in 
the second QOL survey 1 year later had similarly high 
risk of mortality: 3.570 (95%CI: 1.896-6.727), (P < 
0.000); 2.972 (95%CI: 1.622-5.490, P < 0.000), 
respectively. The Hazard Ratios for mortality across 
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categories for PCS and MCS change were: 1.164 
(95%CI: 0.840-2.551), P < 0.178 and 0.706 (95%CI: 
0.404-1.233), P < 0.221 for a change -5 points; 1.205; 
(95%CI 0.606-2.395), P < 0.595 and 1.202 (95%CI: 
0.567-2.546), P < 0.632 for >10 points decline.  
Table 3: Cox proportional hazard multivariate analysis on 
mortality and Physical Component Score (PCS) 
Variable P Hr 95% CI 
Lower upper 
PCS at baseline (< 45) 0.685 1.189 0.514-2.751 
Age (> 65) 0.021 2.030 1.111-3.708 
PCS second survey (< 43) 0.001 2.982 1.556-5.715 
 
In the multivariate model categorising the first 
and second scores as predictors, adjusted for age, 
only the second PCS and MCS score were associated 
with mortality (Table 3 and 4). 
Table 4: Cox proportional hazard multivariate analysis of 
mortality and Mental Component Score (MCS) 
Variable p HR 95% CI 
lower upper 
MCS at baseline (<52) 0.802 1.101 0.520-2.328 
Age (>65) 0.007 2.255 1.245-4.086 
MCS second survey (<50) 0.002 2.583 1.398-4.772 
 
 
 
Discussion 
 
As published before, the study presented here 
found that low physical and mental scores predicted 
mortality [5] [6]. There are few studies addressing the 
impact of the annual change of the quality of life 
scores on mortality. Liebmans group compared the 1-
year mortality rates in patients whose PCS and MCS 
increased or decreased ± 5 points vs those who did 
not. This retrospective study demonstrated an 
increased risk in mortality only for MCS score [7]. In 
the HEMO study, patients older than 70 years showed 
no substantial mean declines in both component 
scores over 3 years [3]. The clinical importance of the 
changes in QOL scores is still under investigation [8] 
[9]. DOPPS study data did not find the score change 
clinically relevant. Only the second QOL score 
predicted outcomes, which implicates the importance 
of frequent measurements and not the sharpness of 
decline. Our study observation is in agreement with 
those findings. Even the decline of 10 points did not 
achieve significance in predicting life quality scores. 
We speculate that marked individual variations of 
change among patients and slightly higher mean 
scores in our dialysis population when compared to 
European patients’-data [7], could contribute to these 
findings.  
In conclusion, deteriorated physical and 
mental aspects of quality of life in hemodialysis 
patients are accompanied by further deterioration. 
Low QOL scores are associated with mortality in 
repeated measurements, but only the more recent 
overwhelmed the power of the decline. Medical, 
psychological and social interventions of preventable 
factors are expected to improve the well-being of 
dialysis patients. Particularly important is the 
increased awareness for the need for regular QOL 
assessments. 
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